PSNL

Personalis (PSNL)

Personalis Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PSNL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/11	11 : 20	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:PSNL	Personalis Inc
2025/01/08	06 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2025/01/08	06 : 01	Business Wire	Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue	NASDAQ:PSNL	Personalis Inc
2024/12/28	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/12/28	06 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PSNL	Personalis Inc
2024/12/19	23 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/12/19	23 : 00	Business Wire	Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna	NASDAQ:PSNL	Personalis Inc
2024/12/19	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/12/19	06 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/12/16	22 : 00	Business Wire	Personalis and Tempus Expand Collaboration to Biopharma	NASDAQ:PSNL	Personalis Inc
2024/11/21	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/11/21	06 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/11/21	06 : 01	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2024/11/07	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PSNL	Personalis Inc
2024/11/07	06 : 01	Business Wire	Personalis Reports Third Quarter 2024 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/11/07	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/11/06	06 : 01	Business Wire	Personalis to Present at the Stifel 2024 Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2024/10/24	05 : 01	Business Wire	Personalis to Announce Third Quarter 2024 Financial Results	NASDAQ:PSNL	Personalis Inc
2024/09/20	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/09/16	22 : 00	Business Wire	ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test	NASDAQ:PSNL	Personalis Inc
2024/09/12	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PSNL	Personalis Inc
2024/08/31	05 : 43	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PSNL	Personalis Inc
2024/08/23	05 : 01	Business Wire	Personalis to Participate at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2024/08/21	05 : 27	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:PSNL	Personalis Inc
2024/08/21	05 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PSNL	Personalis Inc
2024/08/20	05 : 05	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2024/08/16	22 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PSNL	Personalis Inc
2024/08/16	21 : 30	Business Wire	Personalis and Tempus Announce Expanded Collaboration	NASDAQ:PSNL	Personalis Inc
2024/08/08	05 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PSNL	Personalis Inc
2024/08/08	05 : 01	Business Wire	Personalis Reports Second Quarter 2024 Financial Results	NASDAQ:PSNL	Personalis Inc